Vylor's $1.5 billion IPO values its Phase 2 drug highly. Is it justified? See what drives biotech valuations and what to watch next for VYL-001.
·
·
5 min read
Worthington Industries achieved a 15% efficiency boost. See how their investments in advanced materials and automation shape future industrial growth.
·
·
6 min read
How do brands build genuine consumer trust with sustainability? Learn to move beyond green marketing to real action. 70% of consumers prioritize ethics.
·
·
6 min read
2026 currency volatility threatens SME profits. Learn 3 hedging strategies and tools to protect your international trade, from forward contracts to natural
·
·
8 min read
What will 2026 bring for your bonds? See how Fed policy and inflation, projected above 2%, will impact returns and what strategies may protect your investme
·
·
4 min read
The 2026 yield curve inversion warns of a coming recession. Learn why this indicator has predicted every U.S. downturn since 1955 and how to prepare.
·
·
6 min read
C-store M&A rose 15% in Q4 2025. See how indies can compete with niche strategies and AI-driven tech in a consolidating market.
·
·
7 min read
Investment volatility demands new leadership in Q3 2026. See how to protect equity with short-term options and allocate 30% to uncorrelated assets.
·
·
7 min read
78% of C-store shoppers buy private label. See why this matters for retailers, how to grow, and what strategies drive success now.
·
·
6 min read
How did OmniBio tackle 2026 drug pricing pressure for its high-cost specialty meds? See strategies like value-based agreements and cost cuts.
·
·
7 min read